PRICE T ROWE ASSOCIATES INC /MD/ - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 20 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q4 2021$7,294,000
+0.2%
730,8640.0%0.00%0.0%
Q3 2021$7,276,000
-2.3%
730,8640.0%0.00%0.0%
Q2 2021$7,448,000
-6.2%
730,864
-7.1%
0.00%0.0%
Q1 2021$7,940,000
-2.8%
786,890
+2.6%
0.00%0.0%
Q4 2020$8,172,000766,5900.00%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q1 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 248,674$2,452,0000.81%
Wealthspring Capital LLC 138,373$1,365,0000.27%
Cowen Investment Management LLC 100,000$986,0000.21%
Integrity Capital Management (HK) Ltd 3,800$37,0000.19%
Sage Mountain Advisors LLC 94,640$933,0000.15%
Schechter Investment Advisors, LLC 82,802$816,0000.08%
Verition Fund Management LLC 397,603$3,928,0000.05%
Magnetar Financial LLC 450,000$4,446,0000.05%
HGC Investment Management Inc. 79,150$781,0000.05%
RIVERNORTH CAPITAL MANAGEMENT, LLC 75,650$747,0000.03%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders